Business Context and Reporting Period
This Form 6-K filing by Majestic Ideal Holdings Ltd (now Ping An Biomedical Co., Ltd.) covers the month of September 2025. The document reports on the results of an Extraordinary General Meeting (EGM) held on September 12, 2025, in Hong Kong. The primary purpose of the filing is to disclose the shareholder approval of a corporate name change.
Key Corporate Action
Shareholders approved a special resolution to change the company's English name from "Majestic Ideal Holdings Ltd" to "Ping An Biomedical Co., Ltd." and its Chinese name from "宏美控股有限公司" to "平安生物医学有限公司". The change is subject to approval by the Registrar of Companies in the Cayman Islands.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting results rather than financial performance.
Material Changes
The material change disclosed is the formal shareholder authorization to rebrand the entity. There are no reported changes to financial operations or capital structure within this specific filing.
Outlook and Risks
Management commentary is limited to the procedural execution of the name change. The implementation of the new name is contingent upon regulatory approval from the Cayman Islands Registrar of Companies. No specific risks, contingencies, or unusual items regarding financial operations were disclosed in this text.
Investor Verification Checklist
- Voting Participation: Verify that 14,297,969 shares (69.57% of outstanding shares) were represented at the EGM.
- Resolution Approval: Confirm Proposal 1 passed with 14,297,631 votes in favor versus 66 against.
- Regulatory Status: Monitor the Cayman Islands Registrar of Companies for the issuance of the certificate of incorporation on change of name.
- Effective Date: Note that the name change becomes effective only upon the entry of the new name on the Cayman register.